Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated about 16 hours ago
European Medicines Agency (EMA) / European Chemicals Agency (ECHA) joint meeting with industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 June 2026, 09:00 (CEST) to 9 June 2026, 12:00 (CEST)
about 18 hours ago
European Medicines Agency (EMA) / European Chemicals Agency (ECHA) joint meeting with...
Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation: 05/11/2020, Revision: 12, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Date of authorisation: 26/09/2018, Revision: 19, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Date of authorisation...
Human medicines European public assessment report (EPAR): Qdenga, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 05/12/2022, Revision: 7, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Qdenga, dengue tetravalent vaccine (live...
Accelerating Clinical Trials in the EU (ACT EU)
about 18 hours ago
Accelerating Clinical Trials in the EU (ACT EU)
Human medicines European public assessment report (EPAR): Sunosi, solriamfetol, Date of authorisation: 16/01/2020, Revision: 11, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Sunosi, solriamfetol, Date of authorisation...
Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 8, Status: Authorised
about 19 hours ago
Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation...
Timetable: Annual renewal application of conditional marketing authorisation
about 19 hours ago
Timetable: Annual renewal application of conditional marketing authorisation
Timetable: Annual renewal application of conditional marketing authorisation - ATMP
about 19 hours ago
Timetable: Annual renewal application of conditional marketing authorisation - ATMP